Scott Sicherer: Clinical Trials

1 trial sponsored by Scott Sicherer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow Scott Sicherer: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Immune Basis and Clinical Implications of Threshold-based Phenotypes of Peanut Allergy
Peanut Protein, Continued peanut avoidance - Food Allergy, Peanut Allergy
Phase 2CompletedScott Sicherer732019-08-052025-02-07

Conditions studied

Food Hypersensitivity (1)  ·  Hypersensitivity (1)  ·  Peanut Hypersensitivity (1)

Countries

United States (1)

Results publications

PMID 39928078, PMID 42685867

NIH funding

U19AI136053 (1)